Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

3
WISeKey erhöht Umsatzprognosebereich für das erste Halbjahr 2018

2018-07-04 globenewswire
Der ungeprüfte Umsatz im ersten Halbjahr 2018 stieg gegenüber dem bereinigten Umsatz von 18,9 Mio. US-Dollar im ersten Halbjahr 2017 um 36 % auf 25,7 Mio. US-Dollar, angetrieben von höheren Umsätzen in den Bereichen Cybersicherheit, IoT und Halbleiter WISeKey verzeichnet ein starkes sequenzielles Wachstum in den Kernbereichen Cybersicherheit und IoT aufgrund der starken Neukundenakquise und Erweiterung bestehender Kundenkonten
4704 TMICF JNPR CBLK TMICY HPQ

3
WISeKey augmente ses prévisions de chiffre d'affaires pour le 1er semestre

2018-07-04 globenewswire
Les résultats non audités pour le S1 de 2018 ont augmenté de 36 % pour atteindre 25,7 millions de dollars contre 18,9 millions de dollars en revenus ajustés pour le S1 de 2017, grâce à des revenus plus élevés dans les domaines de l'IoT, de la Cybersécurité et des Semi-conducteurs. WISeKey démontre une forte croissance séquentielle sur les activités principales de cybersécurité et d'IoT grâce à une acquisition de clients solide et une croissance des comptes existants
4704 TMICF JNPR CBLK TMICY HPQ

6
Finjan and Trend Micro Enter into Confidential Patent License Agreement

2018-07-02 globenewswire
EAST PALO ALTO, Calif. and SAN JOSE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Finjan Holdings, Inc. (NASDAQ:FNJN), and its subsidiaries, Finjan, Inc. (“Finjan”), Finjan Mobile, Inc. (“Finjan Mobile”), and Finjan Blue, Inc. (“Finjan Blue”), a pioneer in cybersecurity technologies, and Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global leader in cybersecurity solutions, today announced that they had entered into an on-going license arrangement.
4704 TMICF FNJN TMICY

11
WISeKey boosts H1 Revenue guidance range

2018-06-28 globenewswire
H1 2018 unaudited revenue increased by 36% to $25.7 million from $18.9 million adjusted revenue in H1 2017, driven by higher revenues at Cybersecurity IoT and Semiconductor WISeKey shows strong sequential growth on core Cybersecurity and IoT businesses due to robust new customer acquisition and expansion in existing accounts
4704 TMICF JNPR CBLK TMICY HPQ

0
Globalized Bank Hackers Target Sitting Ducks in Latin America

2018-06-12 wolfstreet
The year 2018 is turning out to be a bumper year for the world’s burgeoning ranks of bank hackers. Last week alone, Chile’s second biggest bank, Banco de Chile, reported losing around €10 million in a bank heist targeting the bank’s local SWIFT network. And embattled UK lender TSB admitted that 1,300 customers have been victims of fraud attacks since its botched attempt to upgrade its IT system. That number is likely to continue to rise as the bank struggles to get its act together.
4704 TMICF TMICY

0
A malicious Chrome extension is using Facebook Messenger to target cryptocurrency users

2018-05-04 moneycontrol
A revamped malicious Google Chrome extension has been targeting cryptocurrency exchanges, cybersecurity company Trend Micro reported this week.
4704 TMICF TMICY

1
Tech firms sign pledge to refrain from helping cyberattacks

2018-04-19 technology.inquirer.net
The spate of cyberattacks in the past years has prompted major tech firms to sign a pact to work together, and to agree not to help governments launch offensive measures against innocent parties. Image: Damien Meyer/AFP
4704 TMICF JNPR TMICY

1
Flash - Tech firms sign pledge to refrain from helping cyberattacks - France 24

2018-04-18 france24
Thirty-four global technology companies and organizations signed a pact Tuesday calling for a stronger defense against cyberattacks in any form and pledging to refrain from helping governments attack "innocent" civilians or enterprises.
4704 TMICF JNPR TMICY

224
Billion-Dollar Unicorns: Can Fortinet Get To $10 Billion In Revenue?

2018-04-17 seekingalpha
Fortinet's stock is trading at a 52-week high of $55.82 with a market cap of $9.4 billion.
IBM PFPT SYMC TMICF PANW CHKP GOOG 4704 FEYE AMZN FFIV IMPV GOOGL JNPR QLYS TMICY MSFT ORCL FTNT

1
Tech firms sign pledge to refrain from helping cyberattacks - Channel NewsAsia

2018-04-17 channelnewsasia
SAN FRANCISCO: Thirty-four global technology companies and organisations signed a pact on Tuesday (Apr 17) calling for a stronger defence against cyberattacks in any form and pledging to refrain from helping governments attack "innocent" civilians or enterprises.
4704 TMICF JNPR TMICY

1
Tech firms, including Microsoft, Facebook, vow not to aid government cyber attacks

2018-04-17 channelnewsasia
SAN FRANCISCO: Microsoft, Facebook and more than 30 other global technology companies on Tuesday announced a joint pledge not to assist any government in offensive cyber attacks.
4704 TMICF JNPR TMICY

1
Tech firms, including Microsoft, Facebook, vow not to aid government cyber attacks

2018-04-17 reuters
SAN FRANCISCO (Reuters) - Microsoft, Facebook and more than 30 other global technology companies on Tuesday announced a joint pledge not to assist any government in offensive cyber attacks.
4704 TMICF JNPR TMICY

132
Amazon's (AMZN) AWS Rolls Out S3 Z-IA, Focuses on Innovation

2018-04-05 zacks
Amazon.com, Inc.’s (AMZN - Free Report) subsidiary Amazon Web Services (“AWS”) recently launched a storage service called Amazon S3 Z-IA, which combines the beneficial features of Amazon S3 with the facility of one zone-infrequent access (Z-IA). The new service will allow users to store their infrequently accessed data into a single availability zone instead of multiple zones of AWS that S3 Standard-IA provides.
4704 AMZN TMICF GOOGL VIRT STMP TMICY MSFT

187
3 Tech ETFs and Stocks Unscathed by FAANG Shocks

2018-04-04 investorplace
Tumult in FAANG stocks is now probably the hottest topic of discussion in the investment world. The issue started with the rout in the Facebook Inc (NASDAQ:FB) stock on Mar 19 on reports of data breaches, but finally spread into the other areas of the tech space.
FB 4704 AMZN TMICF TWTR PANW TMICY NFLX CVLT AKAM

97
3 Tech ETFs & Stocks Unscathed by FAANG Shocks

2018-04-04 zacks
Tumult in FAANG stocks is now probably the hottest topic of discussion in the investment world. The issue started with the rout in the Facebook (FB - Free Report) stock on Mar 19 on reports of data breaches, but finally spread into the other areas of the tech space (read: 5 Reason Why FANG ETFs Lost Their Charm in March).
FB 4704 TMICF TWTR PANW TMICY NFLX CVLT AKAM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...